You have 9 free searches left this month | for more free features.

Condition

Chronic Hepatitis B (2)

Chronic HBV Infection (1)

Chronic Hepatitis b (1)

Hepatitis B, Chronic (1)

Overall Status

Unknown status (2)

Active, not recruiting (1)

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (4)

phase 1 (1)

Sponsor

Sunshine Lake Pharma Co., Ltd. (2)

Assembly Biosciences (1)

Janssen Research & Development, LLC (1)

Tongji Hospital (1)

Collaborator

Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (1)

Study Documents

Intervention Type

drug (5)

biological (1)

Funder Type

Industry (4)

Other (1)

Study Type

Interventional (5)

etv

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Chronic Hepatitis B Trial in China (ABI-H0731, ETV, Peg-IFNa)

Active, not recruiting

Chronic Hepatitis B

ABI-H0731
+2 more

Beijing, Beijing, China
+8 more

Mar 17, 2022

Hepatitis B, Chronic Trial in Worldwide (JNJ-73763989, PegIFN-alpha-2a, Tenofovir disoproxil)

Terminated

Hepatitis B, Chronic

JNJ-73763989
+4 more

Hillsborough, New Jersey
+11 more

Dec 28, 2022

Chronic Hepatitis b Trial (ETV, TQ-A3334, TQ-B2450)

Unknown status

Chronic Hepatitis b

ETV
+2 more

(no location specified)

Dec 17, 2019

Chronic Hepatitis B Trial in Changchun (GLS4, RTV, ETV)

Completed

Chronic Hepatitis B

GLS4
+3 more

Changchun, Jilin, China

The First Hospital of Jilin University

Oct 8, 2019

Chronic HBV Infection Trial in China (GLS4, RTV, ETV)

Unknown status

Chronic HBV Infection

GLS4
+2 more

Beijing, Beijing, China
+36 more

Jul 21, 2020